Diametric Capital’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-8,164
Closed -$289K 131
2020
Q2
$289K Buy
+8,164
New +$232K 0.22% 105
2020
Q1
Sell
-19,038
Closed -$411K 128
2019
Q4
$411K Sell
19,038
-11,440
-38% -$262K 0.3% 89
2019
Q3
$689K Buy
30,478
+16,023
+111% +$444K 0.57% 61
2019
Q2
$520K Buy
+14,455
New +$463K 0.33% 72

Other funds holding CDNA

Diametric Capital's CDNA Position: Q3 2020 in Review

Diametric Capital sold out of CareDx (CDNA) in Q3 2020, closing a stake of 8,164 shares — an estimated $289K sold.

Diametric Capital first reported a position in CDNA in Q2 2019 and held it in 4 quarters. The position peaked at $689K in Q3 2019. 197 funds tracked by Wall St. Rank hold CDNA as of Q3 2020.

  • Diametric Capital reported no remaining CareDx position as of Q3 2020 after selling out during the quarter.
  • Diametric Capital sold 8,164 CareDx shares in Q3 2020, an estimated $289K.
  • Diametric Capital first reported a position in CareDx in Q2 2019 and held it in 4 quarters.
  • Diametric Capital's CareDx position peaked at $689K in Q3 2019.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q3 2020.

Based on Diametric Capital's 13F filing for Q3 2020, filed 13 Nov 2020.